Clinical Trial

AtriCure CryoICE Lesions for Persistent and Long-standing Persistent Atrial Fibrillation Treatment

Study acronym: ICE-AFIB
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The primary objective of this study is to evaluate the safety and effectiveness of the AtriCure CryoICE system in performing the Cox-Maze III lesion set, in conjunction with Left Atrial Appendage (LAA) exclusion using the AtriClip device.
Protocol Amendment History 17 amendments
This ClinicalTrials.gov record has been amended 17 times since 2018-11-06; most recent amendment 2026-07-02.
Status change: Recruiting → Active, Not Recruiting 2023-06-01
Status change: Not Yet Recruiting → Recruiting 2019-02-06
Trial Details
NCT Number NCT03732794
Lead Sponsor AtriCure, Inc.
Conditions Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
Enrollment 150 participants
Start Date 2019-01-30
Primary Completion 2024-06-27 (estimated)
Study Completion 2026-06 (estimated)
Updated on ClinicalTrials.gov 2024-10-15